VMP 38897311000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Alfuzosin 10mg modified-release tablets
BNF code 0704010A0AAADAD
Virtual Therapeutic Moiety Alfuzosin
Date identifier became valid 19 Aug 2020
Previous product identifier 326522002
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Alfuzosin hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Besavar XL 10mg tablets (Zentiva Pharma UK Ltd)
Fuzatal XL 10mg tablets (Teva UK Ltd)
Vasran XL 10mg tablets (Sun Pharma UK Ltd)
Xatral XL 10mg tablets (Sanofi)
Xatral XL 10mg tablets (Sigma Pharmaceuticals Plc)
Zochek 10mg modified-release tablets (Milpharm Ltd)
Virtual Medicinal Product Packs
Alfuzosin 10mg modified-release tablets 10 tablet
Alfuzosin 10mg modified-release tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.2.0_20240520000001, imported on 20th May 2024 at 05:03:18.

Feedback